Cancer Immunotherapy: Mechanistic Insights to Improve Clinical Benefit
Organizer(s): Padmanee Sharma, Aviv Regev, Crystal L. Mackall and Kristen HegeDate: March 10 - 14, 2019
Location: Whistler Conference Centre, Whistler, BC, Canada
Cancer immunotherapy is an established field that has led to remarkable clinical benefit for a subset of patients. However, a deeper understanding of the mechanisms of response and resistance to current immunotherapy strategies is needed to help develop new treatments that will increase the number of patients who will benefit. This Keystone Symposia conference is focused on immunotherapy as a treatment for cancer, including potential combination therapies and development of new technologies to elucidate novel targets and/or biomarkers that will be used to design new treatments and enable appropriate patient selection to improve clinical outcomes for cancer patients. The conference will bring together leading and emerging scientists to advance the development of new immune-based treatments for cancer. Discussions will also consider the future directions of the field, including the identification of the most pressing unanswered questions, the areas needing more focus, and those that would benefit from new approaches and methodologies developed and used in other related fields.
Scholarship Deadline: November 20 2018
Discounted Abstract Deadline: November 20 2018
Abstract Deadline: December 5 2018
Discounted Registration Deadline: January 15 2019
We gratefully acknowledge additional support from these exhibitors at this conference:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Arcus Biosciences, Inc.
Forty Seven, Inc.
Jounce Therapeutics, Inc.
We gratefully acknowledge the generous grant for this conference provided by:National Cancer Institute (NCI)
Grant No. 1R13CA236284-01
Funding for this conference was made possible (in part) by 1R13CA236284-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.